Tuesday, June 22, 2010

34 Teachers and Schools Across North America Receive $10,000 Amgen Award for Science Teaching Excellence

THOUSAND OAKS, Calif., June 22, 2010 /PRNewswire via COMTEX/ --Amgen (Nasdaq: AMGN) today announced the 34 science teachers in the United States (U.S.), Canada and Puerto Rico who are this year’s recipients of the 18th annual Amgen Award for Science Teaching Excellence. The award recognizes extraordinary teachers in grades K-12 whose dedication to students has had a significant impact on the learning and interest of the future generation of scientists.

Read the rest of this entry

Posted in Press Releases

Tuesday, June 15, 2010

Amgen to Present at the Goldman Sachs Global Healthcare Conference

THOUSAND OAKS, Calif., June 15, 2010 /PRNewswire via COMTEX/ --Amgen (Nasdaq: AMGN) will present at the Goldman Sachs Global Healthcare Conference on Thursday, June 17, 2010 at the Century Plaza Hyatt Regency, Los Angeles, beginning at 9:20 a.m. Pacific Time. Amgen Chairman and CEO Kevin Sharer will present. Live audio of the presentation will be available over the Internet and can be accessed from Amgen’s website, www.amgen.com, under Investors.

Read the rest of this entry

Posted in Press Releases

Monday, June 07, 2010

Amgen to Present at the Jeffries Global Life Sciences Conference

THOUSAND OAKS, Calif., June 7, 2010 /PRNewswire via COMTEX/ --Amgen (Nasdaq: AMGN) will present at the Jeffries Global Life Sciences Conference at 6:00 a.m. Pacific Time on Wednesday, June 9, 2010, at the Grand Hyatt Hotel in New York City. Amgen’s Roy Baynes, vice president of Global Development and Arvind Sood, vice president of Investor Relations will present at the conference. Live audio of the presentation will be available over the Internet and can be accessed from Amgen’s website, www.amgen.com, under Investors.

Read the rest of this entry

Posted in Press Releases

Sunday, June 06, 2010

New AMG 386 Data Demonstrate Promising Antitumor Activity in Patients With Recurrent Ovarian Cancer

AMG 386 Treatment Response Increased With Dose And Exposure

AMG 386 Moving Into Phase 3 For Recurrent Ovarian Cancer

Separately, Two Analyses Provide Evidence Of Biomarker As Predictor Of Tumor Response To Motesanib

THOUSAND OAKS, Calif., June 6, 2010 /PRNewswire via COMTEX/ --Amgen (Nasdaq: AMGN) today announced that AMG 386, combined with paclitaxel, demonstrated antitumor activity in a randomized Phase 2 trial involving 161 patients with recurrent ovarian cancer.  The results are being presented for the first time in an oral presentation at the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting. (Abstract Number: 5000)

Read the rest of this entry

Posted in Press Releases, Pipeline News

Saturday, June 05, 2010

Striking the Balance: Community Experts Come Together for High-Level Dialogue on Cancer Care

Advocacy Leaders, Renowned Physicians, and Actor Patrick Dempsey Spur Dialogue and Inspire Action in First-of-Its-Kind Roundtable Event

CHICAGO , June 5 /PRNewswire/—Eminent leaders and thinkers in the cancer community came together yesterday at the 2010 American Society of Clinical Oncology (ASCO) annual meeting for a first-of-its-kind roundtable event. The session, sponsored by Amgen and its Breakaway from Cancer (R) initiative, was designed to highlight potential areas for improvement throughout the spectrum of cancer care, and inspire action by establishing several calls-to-action for the cancer community and health policymakers.

Read the rest of this entry

Posted in Press Releases